CRNX

Crinetics Pharmaceuticals, Inc.

40.50 USD
+0.03 (+0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Crinetics Pharmaceuticals, Inc. stock is up 7.43% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 7 PUTs, 3 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
23 Jan 17:29 21 Jun, 2024 40.00 PUT 136 20
24 Jan 19:42 21 Jun, 2024 40.00 PUT 200 155
25 Jan 16:34 21 Jun, 2024 30.00 PUT 112 1068
25 Jan 16:34 21 Jun, 2024 30.00 PUT 112 1068
01 Feb 19:34 19 Apr, 2024 35.00 PUT 221 4
06 Feb 16:13 15 Mar, 2024 40.00 CALL 200 357
09 Feb 20:16 15 Mar, 2024 40.00 PUT 293 2
16 Feb 14:39 15 Mar, 2024 35.00 CALL 80 1685
21 Feb 19:18 19 Apr, 2024 35.00 PUT 218 255
27 Feb 18:03 21 Jun, 2024 40.00 CALL 50 265

About Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism.